2025 Talent & Salary Report: Trends In The Dutch Biotech Industry

Building Competitive Hiring Strategies in 2025

Biotech companies in the Netherlands are facing a new recruitment reality. Rapid advances in cell & gene therapy, biologics, and oncology are creating demand for cross-functional experts who can operate at the intersection of science, regulation, and innovation.

Traditional hiring approaches are falling short in attracting QA, RA, and Clinical specialists with niche expertise. The most successful teams are rethinking how they attract, assess, and retain talent, building capabilities that combine technical excellence with compliance, speed, and innovation.

Navigating Growth and Challenges

While Dutch biotech is expanding with large-scale investments, world-class research, and government support, growth is not evenly distributed. New company formation is slowing, and bottlenecks in regulation, commercialisation, and infrastructure remain. This imbalance is mirrored in talent: specialists are scarce, competition is driving salaries upward, and professionals are increasingly seeking meaningful work, flexibility, and growth opportunities.